- Home
- SLQT vs PCRX Comparison
SLQT vs PCRX Comparison
Compare SLQT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- PCRX
- Stock Information
- Founded
- SLQT 1999
- PCRX 2006
- Country
- SLQT United States
- PCRX United States
- Employees
- SLQT N/A
- PCRX N/A
- Industry
- SLQT Specialty Insurers
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- PCRX Health Care
- Exchange
- SLQT Nasdaq
- PCRX Nasdaq
- Market Cap
- SLQT 682.6M
- PCRX 604.7M
- IPO Year
- SLQT 2020
- PCRX 2011
- Fundamental
- Price
- SLQT $4.45
- PCRX $24.52
- Analyst Decision
- SLQT Hold
- PCRX Buy
- Analyst Count
- SLQT 1
- PCRX 10
- Target Price
- SLQT $4.00
- PCRX $27.60
- AVG Volume (30 Days)
- SLQT 1.3M
- PCRX 741.3K
- Earning Date
- SLQT 02-05-2025
- PCRX 02-27-2025
- Dividend Yield
- SLQT N/A
- PCRX N/A
- EPS Growth
- SLQT N/A
- PCRX N/A
- EPS
- SLQT N/A
- PCRX N/A
- Revenue
- SLQT $1,381,309,000.00
- PCRX $694,957,000.00
- Revenue This Year
- SLQT $12.73
- PCRX $4.83
- Revenue Next Year
- SLQT $14.03
- PCRX $2.16
- P/E Ratio
- SLQT N/A
- PCRX N/A
- Revenue Growth
- SLQT 28.72
- PCRX 4.40
- 52 Week Low
- SLQT $1.08
- PCRX $11.16
- 52 Week High
- SLQT $4.64
- PCRX $34.01
- Technical
- Relative Strength Index (RSI)
- SLQT 70.34
- PCRX 76.79
- Support Level
- SLQT $4.21
- PCRX $18.18
- Resistance Level
- SLQT $4.62
- PCRX $22.36
- Average True Range (ATR)
- SLQT 0.30
- PCRX 1.28
- MACD
- SLQT 0.02
- PCRX 0.39
- Stochastic Oscillator
- SLQT 82.16
- PCRX 89.19
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.